Biofrontera AG engages in the research, development, and marketing of dermatological products. Its products include Ameluz, BF-RhodolesXepi and Belixos. The company was founded by Hermann Lübbert in 1997 and is headquartered in Leverkusen, Germany.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Biofrontera AG - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Biofrontera AG - ADR market cap is $70.33M.
What is the 52-week high for Biofrontera AG - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Biofrontera AG - ADR 52 week high is $6.89 as of October 30, 2025.
What is the 52-week low for Biofrontera AG - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Biofrontera AG - ADR 52 week low is $1.50 as of October 30, 2025.
What is Biofrontera AG - ADR stock price today?
Biofrontera AG - ADR stock price today is $2.48.
What was Biofrontera AG - ADR stock price yesterday?
Biofrontera AG - ADR stock price yesterday was $2.43.
What is the PE ratio of Biofrontera AG - ADR?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Biofrontera AG - ADR’s P/E ratio is 5.41.
What is the Price-to-Book ratio of Biofrontera AG - ADR?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Biofrontera AG - ADR P/B ratio is 3.1613.
What is Biofrontera AG - ADR's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Biofrontera AG - ADR's EBITDA is N/A.
What is the 50-day moving average of Biofrontera AG - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Biofrontera AG - ADR 50-day moving average is $2.35.
